Valuation: CStone Pharmaceuticals

Market Cap 7.89B 1.17B 1.01B 951M 864M 1.63B 112B 1.66B 11.15B 4.36B 56.01B 4.4B 4.3B 187B P/E 2026 *
-370x
P/E 2027 * 7.37x
Enterprise Value 7.36B 1.09B 944M 888M 807M 1.52B 104B 1.54B 10.4B 4.06B 52.26B 4.11B 4.02B 174B EV / Sales 2026 *
15.4x
EV / Sales 2027 * 2.5x
Free-Float
80.15%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day-0.39%
1 week+22.60%
Current month+32.06%
1 month+14.59%
3 months-26.01%
6 months-0.42%
Current year+8.32%
1 week 0.57
Extreme 0.5666
0.64
1 month 0.45
Extreme 0.4471
0.64
Current year 0.45
Extreme 0.4471
1.12
1 year 0.45
Extreme 0.4471
1.35
3 years 0.09
Extreme 0.092
1.35
5 years 0.09
Extreme 0.092
1.55
10 years 0.09
Extreme 0.092
1.98
Manager TitleAgeSince
Chief Executive Officer 62 2022-08-24
Director of Finance/CFO - 2023-01-17
Chief Operating Officer 46 2016-07-31
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 2022-08-24
Director/Board Member 63 2021-07-08
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%+22.60% - - 1.18B
-0.31%+4.06%+43.08%-0.43% 80.48B
-1.02%+2.25%-3.19%+25.69% 51.06B
-3.10%-5.64%+11.56%+158.84% 48.19B
-0.74%+3.13%-49.36%-48.70% 46.5B
-0.39%+1.72%+55.21%-23.33% 31.12B
-0.52%+17.56%+135.48%-37.61% 25.41B
-0.30%+1.50%+39.97%+82.25% 24.43B
-1.42%+3.13%-1.26%+182.96% 21.11B
-1.83%-1.21%+59.91%+107.34% 16.28B
Average -0.94%+3.52%+32.38%+49.67% 38.29B
Weighted average by Cap. -0.98%+2.96%+25.11%+36.58%

Financials

2026 *2027 *
Net sales 479M 71.2M 61.43M 57.78M 52.51M 98.92M 6.79B 101M 677M 265M 3.4B 267M 261M 11.34B 1.71B 254M 220M 207M 188M 354M 24.28B 359M 2.42B 946M 12.16B 955M 935M 40.54B
Net income -243M -36.13M -31.17M -29.32M -26.64M -50.19M -3.45B -51.02M -344M -134M -1.73B -136M -133M -5.75B 687M 102M 88.1M 82.87M 75.31M 142M 9.74B 144M 971M 379M 4.88B 383M 375M 16.27B
Net Debt -528M -78.46M -67.7M -63.67M -57.86M -109M -7.49B -111M -746M -292M -3.75B -295M -288M -12.5B -3.6B -535M -462M -434M -395M -744M -51.07B -756M -5.09B -1.99B -25.57B -2.01B -1.97B -85.26B
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
136
Date Price Change
26-08-14 €0.6174 -0.39%
26-08-13 €0.6198 -0.16%
26-08-12 €0.6208 -2.60%
26-08-11 €0.6374 +12.50%
26-08-10 €0.5666 +0.93%
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.938CNY
Average target price
12.33CNY
Spread / Average Target
+149.75%

Quarterly revenue - Rate of surprise